These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25712794)

  • 1. Drug susceptibility and molecular epidemiology of Escherichia coli in bloodstream infections in Shanghai, China, 2011-2013.
    Zhao SY; Wang YC; Xiao SZ; Jiang XF; Guo XK; Ni YX; Han LZ
    Infect Dis (Lond); 2015 May; 47(5):310-8. PubMed ID: 25712794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China.
    Wang S; Zhao SY; Xiao SZ; Gu FF; Liu QZ; Tang J; Guo XK; Ni YX; Han LZ
    PLoS One; 2016; 11(1):e0147740. PubMed ID: 26824702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
    Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
    PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.
    Zhang C; Xu X; Pu S; Huang S; Sun J; Yang S; Zhang L
    Infect Genet Evol; 2014 Oct; 27():271-6. PubMed ID: 25107431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bloodstream infections with
    Zhong Y; Zhang X; Liu W; Yang F; Yan Q; Liu Q; Li Y; Li H; Zou M
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1521-1526. PubMed ID: 30613024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?
    Ewers C; Bethe A; Stamm I; Grobbel M; Kopp PA; Guerra B; Stubbe M; Doi Y; Zong Z; Kola A; Schaufler K; Semmler T; Fruth A; Wieler LH; Guenther S
    J Antimicrob Chemother; 2014 May; 69(5):1224-30. PubMed ID: 24398338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; de Cueto M; Ríos MJ; Hernández JR; Pascual A
    Clin Infect Dis; 2006 Dec; 43(11):1407-14. PubMed ID: 17083012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
    Hansen F; Olsen SS; Heltberg O; Justesen US; Fuglsang-Damgaard D; Knudsen JD; Hammerum AM
    Microb Drug Resist; 2014 Aug; 20(4):316-24. PubMed ID: 24517383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESBL-producing Escherichia coli isolated from bloodstream infections--antimicrobial susceptibility, conjugative transfer of resistance genes and phylogenetic origin.
    Franiczek R; Krzyżanowska B
    Adv Clin Exp Med; 2014; 23(6):865-70. PubMed ID: 25618110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.
    Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Blanco JE; Alonso MP; García-Garrote F; Chaves F; Orellana MÁ; Martínez-Martínez L; Calvo J; Prats G; Larrosa MN; González-López JJ; López-Cerero L; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2011 Sep; 66(9):2011-21. PubMed ID: 21669946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
    Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.
    Liao K; Chen Y; Wang M; Guo P; Yang Q; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Xu Y
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):45-48. PubMed ID: 27773544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Resistance and Molecular Epidemiology of Uropathogenic
    Zeng Q; Xiao S; Gu F; He W; Xie Q; Yu F; Han L
    Front Cell Infect Microbiol; 2021; 11():653983. PubMed ID: 34485168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WGS-based surveillance of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
    Roer L; Hansen F; Thomsen MCF; Knudsen JD; Hansen DS; Wang M; Samulioniené J; Justesen US; Røder BL; Schumacher H; Østergaard C; Andersen LP; Dzajic E; Søndergaard TS; Stegger M; Hammerum AM; Hasman H
    J Antimicrob Chemother; 2017 Jul; 72(7):1922-1929. PubMed ID: 28369408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.
    Zhong YM; Liu WE; Liang XH; Li YM; Jian ZJ; Hawkey PM
    J Antimicrob Chemother; 2015 Aug; 70(8):2223-7. PubMed ID: 25957581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.